Central Nervous System Manifestations in Systemic Lupus Erythematosus

被引:3
作者
Appenzeller, Simone [1 ,2 ]
Lavras Costallat, Lilian Tereza [1 ]
Cendes, Fernando [2 ,3 ]
机构
[1] Univ Estadual Campinas, Rheumatol Unit, Campinas, SP, Brazil
[2] Univ Estadual Campinas, Neuroimaging Lab, Campinas, SP, Brazil
[3] Univ Estadual Campinas, Dept Neurol, Campinas, SP, Brazil
基金
巴西圣保罗研究基金会;
关键词
CNS involvement; SLE;
D O I
10.2174/157339707781387572
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Neurologists and rheumatologist are often called to evaluate central nervous system (CNS) manifestations in patients with suspected or definite systemic lupus erythematosus (SLE). The manifestations are highly diverse and often have major prognostic consequences. The major difficulties are to determine if the given manifestation is primarily due to SLE activity in the brain, or a consequence of metabolic disturbances, infection, or corticosteroid use. The true incidence of CNS manifestations attributable to SLE is not entirely clear, but several studies show prevalence rate between 15-75%, depending on different methods and classification criteria applied. This paper has the objective to review the main clinical manifestations according to American College of Rheumatology (ACR) criteria, possible etiological mechanisms and neuroimaging features associated with these manifestations. We further discuss the most important tools that can help bedside diagnosis.
引用
收藏
页码:205 / 214
页数:10
相关论文
共 138 条
[1]   The blood-brain barrier in systemic lupus erythematosus [J].
Abbott, NJ ;
Mendonça, LLF ;
Dolman, DEM .
LUPUS, 2003, 12 (12) :908-915
[2]   Neuropsychiatric lupus syndromes -: Relationship with antiphospholipid antibodies [J].
Afeltra, A ;
Garzia, P ;
Mitterhofer, AP ;
Vadacca, M ;
Galluzzo, S ;
Del Porto, F ;
Finamore, L ;
Pascucci, S ;
Gasparini, M ;
Laganà, B ;
Caccavo, D ;
Ferri, GM ;
Amoroso, A ;
Francia, A .
NEUROLOGY, 2003, 61 (01) :108-110
[3]   Increased serum matrix metalloproteinase 9 levels in systemic lupus erythematosus patients with neuropsychiatric manifestations and brain magnetic resonance imaging abnormalities [J].
Ainiala, H ;
Hietaharju, A ;
Dastidar, P ;
Loukkola, J ;
Lehtimäki, T ;
Peltola, J ;
Korpela, M ;
Heinonen, T ;
Nikkari, ST .
ARTHRITIS AND RHEUMATISM, 2004, 50 (03) :858-865
[4]   The prevalence of neuropsychiatric syndromes in systemic lupus erythematosus [J].
Ainiala, H ;
Loukkola, J ;
Peltola, J ;
Korpela, M ;
Hietaharju, A .
NEUROLOGY, 2001, 57 (03) :496-500
[5]  
Ainiala H, 2001, ARTHRIT RHEUM-ARTHR, V45, P419, DOI 10.1002/1529-0131(200110)45:5<419::AID-ART360>3.0.CO
[6]  
2-X
[7]  
Akbarian S, 1996, J NEUROSCI, V16, P19
[8]   Hippocampal atrophy in systemic lupus erythematosus [J].
Appenzeller, S. ;
D Carnevalle, A. ;
Li, L. M. ;
Costallat, L. T. L. ;
Cendes, F. .
ANNALS OF THE RHEUMATIC DISEASES, 2006, 65 (12) :1585-1589
[9]   Cerebral venous thrombosis: influence of risk factors and imaging findings on prognosis [J].
Appenzeller, S ;
Zeller, CB ;
Annichino-Bizzachi, JM ;
Costallat, LTL ;
Deus-Silva, L ;
Voetsch, B ;
Faria, AV ;
Zanardi, VA ;
Damasceno, BP ;
Cendes, F .
CLINICAL NEUROLOGY AND NEUROSURGERY, 2005, 107 (05) :371-378
[10]   Evidence of reversible axonal dysfunction in systemic lupus erythematosus: a proton MRS study [J].
Appenzeller, S ;
Li, LM ;
Costallat, LTL ;
Cendes, F .
BRAIN, 2005, 128 :2933-2940